https://www.selleckchem.com/pr....oducts/chroman-1.htm
Chemotherapy-induced nausea and vomiting (CINV) commonly occurs after chemotherapy, adversely affecting patients' quality of life. Recently, studies have shown inconsistent antiemetic effects of two common 5-hydroxytryptamine 3 receptor antagonists, namely, palonosetron and granisetron. Therefore, we conducted a meta-analysis to evaluate the effectiveness of palonosetron versus granisetron in preventing CINV. Relevant studies were obtained from PubMed, Embase, and Cochrane databases. The primary outcome was the complete response (CR)
Like
Comment
Share
